LRRC4 inhibits the proliferation of human glioma cells by modulating the expression of STMN1 and microtubule polymerization

Journal of Cellular Biochemistry

Volumn 112, Issue 12, 2011, Pages 3621-3629

  Wu, Minghua ^a,b,c   Wang, Rong ^a,b,c   Wang, Zeyou ^a,b,c   Yang, Jing ^a,b,c   Liu, Xiaoping ^a,b,c   Wang, Li ^a,b,c   Guo, Xiaofang ^a,b,c   Zeng, Fang ^a,b,c   Li, Guiyuan ^a,b,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

Cell cycling; Glioma cells; LRRC4; Microtubin polymerization; Proliferation; STMN1

Indexed keywords

CYCLIN B; CYCLIN D1; CYCLIN DEPENDENT KINASE 5; LEUCINE RICH REPEAT C4 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; PROTEIN P21; SMALL INTERFERING RNA; STATHMIN 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE SILENCING; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROTUBULE ASSEMBLY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

ANIMALS; BASE SEQUENCE; BIOPOLYMERS; BRAIN NEOPLASMS; CELL PROLIFERATION; DNA PRIMERS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLIOMA; HUMANS; MICE; MICE, NUDE; NERVE TISSUE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STATHMIN; TANDEM MASS SPECTROMETRY;

EID: 80055017419     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23293     Document Type: Article

References (25)

1. Ahn J, Murphy M, Kratowicz S, Wang a, Levine AJ, George DL,. 1999. Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction. Oncogene 18: 5954-5958. (Pubitemid 29520452)
2. Budhachandra K, Brojen Singh RK, Menon GI,. 2008. Microtubule dynamics regulated by stathmin. Comput Biol Chem 32: 141-144.
3. Chen G, Wang H, Gharib TG, Huang CC, Thomas DG, Shedden KA, Kuick R, Taylor JM, Kardia SL, Misek DE, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG,. 2003. Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas. Mol Cell Proteomics 2: 107-116.
4. Cilia M, Fish T, Yang X, Mclaughlin M, Thannhauser TW, Gray S,. 2009. A comparison of protein extraction methods suitable for gel-based proteomic studies of aphid proteins. J Biomol Tech 20: 201-215.
5. Fan SQ, Ma J, Zhou J, Xiong W, Xiao BY, Zhang WL, Tan C, Li XL, Shen SR, Zhou M, Zhang QH, Ou YJ, Zhou HD, Zhou YH, Li GY,. 2006. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis. Hum Pathol 37: 593-605.
6. Hayashi K, Pan Y, Shu H, Ohshima T, Kansy JW, White CL, Tamminga CA, Sobel A, Curmi PA, Mikoshiba K, Bibb JA,. 2006. Phosphorylation of the tubulin-binding protein, stathmin, by Cdk5 and MAP kinase in the brain. J Neurochem 1: 237-250. (Pubitemid 44395146)
7. Holmfeldt P, Sellin ME, Gullberg M,. 2009. Predominant regulators of tubulin monomer-polymer partitioning and their implication for cell polarization. Cell Mol Life Sci 66: 3263-3276.
8. Johnsen JI, Aurelio ON, Kwaja Z, Jorgensen GE, Pellegata NS, Plattner R, Stanbridge EJ, Cajot JF,. 2000. p53-mediated negative regulation of stathmin/Op18 expression is associated with G(2)/M cell-cycle arrest. Int J Cancer 88: 685-691.
9. Lin X, Liu S, Luo X, Ma X, Guo L, Li L, Li Z, Tao Y, Cao Y,. 2009. EBV-encoded LMP1 regulates Op18/stathmin signaling pathway by cdc2 mediation in nasopharyngeal carcinoma cells. Int J Cancer 124: 1020-1027.
10. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P,. 2007. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109. (Pubitemid 47103521)
11. Mistry SJ, Atweh GF,. 2002. Role of stathmin in the regulation of the mitotic spindle: Potential applications in cancer therapy. Mt Sinai J Med 69: 299-304. (Pubitemid 35244131)
12. Polzin RG, Benlhabib H, Trepel J, Herrera JE,. 2004. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M. Gene 341: 209-218. (Pubitemid 39335896)
13. Romanov VS, Brichkina AI, Pospelov VA, Pospelova TV,. 2005. E1A oncogene effect on the ability of p21(Waf1) to regulate G1/S arrest in E1A-expressing transformants following irradiation. Tsitologiia 47: 1063-1070.
14. Schmider-Ross A, Pirsig O, Gottschalk E, Denkert C, Lichtenegger W, Reles A,. 2006. Cyclin-dependent kinase inhibitors CIP1 (p21) and KIP1 (p27) in ovarian cancer. J Cancer Res Clin Oncol 132: 163-170. (Pubitemid 43015777)
15. Sellin ME, Holmfeldt P, Stenmark S, Gullberg M,. 2008. Global regulation of the interphase microtubule system by abundantly expressed Op18/stathmin. Mol Biol Cell 19: 2897-2906.
16. Srivastava RK, Chen Q, Siddiqui I, Sarva K, Shankar S,. 2007. Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1). Cell Cycle 6: 2953-2961.
17. Steinman RA, Yaroslavskiy B, Kaplan SS, Goff JP, Shields DS,. 2000. Clonal response of K562 leukemic cells to exogenous p21WAF1. Leuk Res 24: 601-610. (Pubitemid 30365111)
18. Wang JR, Qian J, Dong L, Li XL, Tan C, Li J, Zhang BC, Zhou J, Li GY,. 2002. Identification of LRRC4, a novel member of leucine-rich repeat (LRR) superfamily, and its expression analysis in brain tumor. Prog Biochem Biophys 29: 233-239. (Pubitemid 35007732)
19. Wu M, Huang C, Gan K, Huang H, Chen Q, Ouyang J, Tang Y, Li X, Yang Y, Zhou H, Zhou Y, Zeng Z, Xiao L, Li D, Tang K, Shen S, Li G,. 2006a. LRRC4, a putative tumor suppressor gene, requires a functional leucine-rich repeat cassette domain to inhibit proliferation of glioma cells in vitro by modulating the extracellular signal-regulated kinase/protein kinase B/nuclear factor-kappaB pathway. Mol Biol Cell 17: 3534-3542. (Pubitemid 44156446)
20. Wu M, Huang C, Li X, Li X, Gan K, Chen Q, Tang Y, Tang K, Shen S, Li G,. 2008a. LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses. J Cell Physiol 214: 65-74. (Pubitemid 350220060)
21. Wu M, Gan K, Huang C, Tang Y, Chen Q, Tang K, Li X, Shen S, Li G,. 2006b. LRRC4 controls in vitro invasion of glioblastoma cells through inhibiting RPTP-zeta expression. J Neurooncol 80: 133-142. (Pubitemid 44614793)
22. Wu M, Chen Q, Li D, Li X, Li X, Huang C, Tang Y, Zhou Y, Wang D, Tang K, Cao L, Shen S, Li G,. 2008b. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways. J Cell Biochem 103: 245-255.
23. Zhang QH, Wu MH, Wang LL, Cao L, Tang K, Peng C, Gan K, Li XL, Li GY,. 2005a. Profiling of differentially expressed genes in LRRC4 overexpressed glioblastoma cells by cDNA array. Acta Biochim Biophys Sin (Shanghai) 37: 680-687. (Pubitemid 43142193)
24. Zhang Q, Wang J, Fan S, Wang L, Cao L, Tang K, Peng C, Li Z, Li W, Gan K, Liu Z, Li X, Shen S, Li G,. 2005b. Expression and functional characterization of LRRC4, a novel brain-specific member of the LRR superfamily. FEBS Lett 579: 3674-3682. (Pubitemid 40897708)
25. Zhang Z, Li D, Wu M, Xiang B, Wang L, Zhou M, Chen P, Li X, Shen S, Li G,. 2008. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas. BMC Mol Biol 9: 99.